The Biden administration’s recently announced plan to replace all lead pipes in the U.S. is a reminder that the toxic metal remains a threat, even in a country that has largely banned its use.
Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC
Plus, news about Longevity Biomedical, Sensorion, Teva and Bristol Myers Squibb: Context Therapeutics buys a T cell engager: The biotech will Sign up to read